159 related articles for article (PubMed ID: 34116068)
1. Medical contraindications to combined hormonal contraceptive use among women using methods prescribed by a pharmacist.
Rodriguez MI; Kaufman M; Manibusan B; Anderson L; McConnell KJ
Contraception; 2021 Nov; 104(5):547-552. PubMed ID: 34116068
[TBL] [Abstract][Full Text] [Related]
2. Association of Pharmacist Prescription of Contraception With Breaks in Coverage.
Rodriguez MI; Manibusan B; Kaufman M; McConnell KJ
Obstet Gynecol; 2022 May; 139(5):781-787. PubMed ID: 35576337
[TBL] [Abstract][Full Text] [Related]
3. Association of Pharmacist Prescription With Dispensed Duration of Hormonal Contraception.
Rodriguez MI; Edelman AB; Skye M; Anderson L; Darney BG
JAMA Netw Open; 2020 May; 3(5):e205252. PubMed ID: 32432710
[TBL] [Abstract][Full Text] [Related]
4. Pharmacist prescription and access to hormonal contraception for Medicaid-insured women in Oregon.
Gibbs SE; Harvey SM
Contraception; 2020 Oct; 102(4):262-266. PubMed ID: 32652093
[TBL] [Abstract][Full Text] [Related]
5. Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.
Lauring JR; Lehman EB; Deimling TA; Legro RS; Chuang CH
Am J Obstet Gynecol; 2016 Sep; 215(3):330.e1-7. PubMed ID: 27059507
[TBL] [Abstract][Full Text] [Related]
6. Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid Population.
Anderson L; Hartung DM; Middleton L; Rodriguez MI
Obstet Gynecol; 2019 Jun; 133(6):1231-1237. PubMed ID: 31135739
[TBL] [Abstract][Full Text] [Related]
7. Association of pharmacist prescription and 12-month contraceptive continuation rates.
Rodriguez MI; Skye M; Edelman AB; Anderson L; Darney BG
Am J Obstet Gynecol; 2021 Dec; 225(6):647.e1-647.e9. PubMed ID: 34217725
[TBL] [Abstract][Full Text] [Related]
8. Medical contraindications to estrogen and contraceptive use among women veterans.
Judge CP; Zhao X; Sileanu FE; Mor MK; Borrero S
Am J Obstet Gynecol; 2018 Feb; 218(2):234.e1-234.e9. PubMed ID: 29111146
[TBL] [Abstract][Full Text] [Related]
9. Contraindications to Hormonal Contraception Among Postpartum Women in Texas.
Coleman-Minahan K; Ela EJ; White K; Grossman D
Obstet Gynecol; 2021 May; 137(5):907-915. PubMed ID: 33831931
[TBL] [Abstract][Full Text] [Related]
10. Assessing pharmacist and clinician perspectives on pharmacist-prescribed hormonal contraceptives.
Whalen A; Bratberg J; Cohen L; Orr K; Lemay V
J Am Pharm Assoc (2003); 2024; 64(1):314-320.e3. PubMed ID: 37967721
[TBL] [Abstract][Full Text] [Related]
11. Association of Pharmacist Prescription of Hormonal Contraception With Unintended Pregnancies and Medicaid Costs.
Rodriguez MI; Hersh A; Anderson LB; Hartung DM; Edelman AB
Obstet Gynecol; 2019 Jun; 133(6):1238-1246. PubMed ID: 31135740
[TBL] [Abstract][Full Text] [Related]
12. Characterizing pharmacist-prescribed hormonal contraception services and users in California and Oregon pharmacies.
Lu S; Rafie S; Hamper J; Strauss R; Kroon L
Contraception; 2019 Apr; 99(4):239-243. PubMed ID: 30562478
[TBL] [Abstract][Full Text] [Related]
13. North Carolina Pharmacists' Support for Hormonal Contraception Prescription Status Change.
Parry RA; Seamon G; Scott MA; Tak CR
J Pharm Pract; 2023 Aug; 36(4):769-776. PubMed ID: 35325584
[TBL] [Abstract][Full Text] [Related]
14. Contraceptive Use Among Women in the United States Aged 18-44 Years with Selected Medical Contraindications to Estrogen.
Erly SJ; Forward TR; Rogers ZH; Hawes SE; Micks E
J Womens Health (Larchmt); 2022 Apr; 31(4):580-585. PubMed ID: 34491112
[No Abstract] [Full Text] [Related]
15. Community perspectives on pharmacist-prescribed hormonal contraception in rural California.
Gomez AM; Rafie S; Garner-Ford E; Arcara J; Arteaga S; Britter M; De La Cruz M; Gleaton SK; Gomez-Vidal C; Luna B; Ortiz C; Rivera MC; Schuman L; Watanabe M; Logan R
Contraception; 2022 Oct; 114():10-17. PubMed ID: 35671841
[TBL] [Abstract][Full Text] [Related]
16. Implementation of a pharmacist-led hormonal contraceptive prescribing service in a campus community pharmacy in Indiana, United States.
Ahmad ZM; Noel NL; Rudd TM; Nadelson CS; Ott MA; Wilkinson TA; Meredith AH
Contraception; 2022 Sep; 113():113-118. PubMed ID: 35577148
[TBL] [Abstract][Full Text] [Related]
17. Canadian Contraception Consensus (Part 2 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
[TBL] [Abstract][Full Text] [Related]
18. Canadian Contraception Consensus (Part 1 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
[TBL] [Abstract][Full Text] [Related]
19. Association Between Oregon's 12-Month Contraceptive Supply Policy and Quantity of Contraceptives Dispensed.
Rodriguez MI; Lin SC; Steenland M; McConnell KJ
JAMA Health Forum; 2022 Feb; 3(2):e215146. PubMed ID: 35977278
[TBL] [Abstract][Full Text] [Related]
20. Trends in contraceptive use according to HIV status among privately insured women in the United States.
Haddad LB; Monsour M; Tepper NK; Whiteman MK; Kourtis AP; Jamieson DJ
Am J Obstet Gynecol; 2017 Dec; 217(6):676.e1-676.e11. PubMed ID: 28866122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
